Cargando…

Development of a physiological insulin resistance model in human stem cell–derived adipocytes

Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to...

Descripción completa

Detalles Bibliográficos
Autores principales: Friesen, Max, Khalil, Andrew S., Barrasa, M. Inmaculada, Jeppesen, Jacob F., Mooney, David J., Jaenisch, Rudolf
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for the Advancement of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205586/
https://www.ncbi.nlm.nih.gov/pubmed/35714187
http://dx.doi.org/10.1126/sciadv.abn7298
_version_ 1784729162220568576
author Friesen, Max
Khalil, Andrew S.
Barrasa, M. Inmaculada
Jeppesen, Jacob F.
Mooney, David J.
Jaenisch, Rudolf
author_facet Friesen, Max
Khalil, Andrew S.
Barrasa, M. Inmaculada
Jeppesen, Jacob F.
Mooney, David J.
Jaenisch, Rudolf
author_sort Friesen, Max
collection PubMed
description Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to the dearth of suitable models of insulin signaling in human adipocytes. Traditionally, adipocyte models fail to recapitulate in vivo insulin signaling, possibly due to exposure to supraphysiological nutrient and hormone conditions. We developed a protocol for human pluripotent stem cell–derived adipocytes that uses physiological nutrient conditions to produce a potent insulin response comparable to in vivo adipocytes. After systematic optimization, this protocol allows robust insulin-stimulated glucose uptake and transcriptional insulin response. Furthermore, exposure of sensitized adipocytes to physiological hyperinsulinemia dampens insulin-stimulated glucose uptake and dysregulates insulin-responsive transcription. Overall, our methodology provides a novel platform for the mechanistic study of insulin signaling and resistance using human pluripotent stem cell–derived adipocytes.
format Online
Article
Text
id pubmed-9205586
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Association for the Advancement of Science
record_format MEDLINE/PubMed
spelling pubmed-92055862022-06-29 Development of a physiological insulin resistance model in human stem cell–derived adipocytes Friesen, Max Khalil, Andrew S. Barrasa, M. Inmaculada Jeppesen, Jacob F. Mooney, David J. Jaenisch, Rudolf Sci Adv Biomedicine and Life Sciences Adipocytes are key regulators of human metabolism, and their dysfunction in insulin signaling is central to metabolic diseases including type II diabetes mellitus (T2D). However, the progression of insulin resistance into T2D is still poorly understood. This limited understanding is due, in part, to the dearth of suitable models of insulin signaling in human adipocytes. Traditionally, adipocyte models fail to recapitulate in vivo insulin signaling, possibly due to exposure to supraphysiological nutrient and hormone conditions. We developed a protocol for human pluripotent stem cell–derived adipocytes that uses physiological nutrient conditions to produce a potent insulin response comparable to in vivo adipocytes. After systematic optimization, this protocol allows robust insulin-stimulated glucose uptake and transcriptional insulin response. Furthermore, exposure of sensitized adipocytes to physiological hyperinsulinemia dampens insulin-stimulated glucose uptake and dysregulates insulin-responsive transcription. Overall, our methodology provides a novel platform for the mechanistic study of insulin signaling and resistance using human pluripotent stem cell–derived adipocytes. American Association for the Advancement of Science 2022-06-17 /pmc/articles/PMC9205586/ /pubmed/35714187 http://dx.doi.org/10.1126/sciadv.abn7298 Text en Copyright © 2022 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution NonCommercial License 4.0 (CC BY-NC). https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial license (https://creativecommons.org/licenses/by-nc/4.0/) , which permits use, distribution, and reproduction in any medium, so long as the resultant use is not for commercial advantage and provided the original work is properly cited.
spellingShingle Biomedicine and Life Sciences
Friesen, Max
Khalil, Andrew S.
Barrasa, M. Inmaculada
Jeppesen, Jacob F.
Mooney, David J.
Jaenisch, Rudolf
Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title_full Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title_fullStr Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title_full_unstemmed Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title_short Development of a physiological insulin resistance model in human stem cell–derived adipocytes
title_sort development of a physiological insulin resistance model in human stem cell–derived adipocytes
topic Biomedicine and Life Sciences
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205586/
https://www.ncbi.nlm.nih.gov/pubmed/35714187
http://dx.doi.org/10.1126/sciadv.abn7298
work_keys_str_mv AT friesenmax developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes
AT khalilandrews developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes
AT barrasaminmaculada developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes
AT jeppesenjacobf developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes
AT mooneydavidj developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes
AT jaenischrudolf developmentofaphysiologicalinsulinresistancemodelinhumanstemcellderivedadipocytes